Bubendorf, Switzerland

Bachem Holding

Bubendorf peptide CDMO supplying nutraceutical peptides.

Founded in 1971, Bachem operates as a Contract Development and Manufacturing Organisation (CDMO) with over 50 years of experience in peptides and oligonucleotides. The company provides end-to-end services spanning early clinical development through commercial-scale GMP supply. For peptides, Bachem offers clinical development support, commercial GMP manufacturing of peptide APIs, custom synthesis for research, amino acid derivatives and building blocks, cosmetic peptides, and peptides for diagnostics and medical devices. The oligonucleotide platform includes single-strand oligos, duplex APIs such as siRNA, antisense oligonucleotides, and conjugates including GalNAc, manufactured under GMP conditions from clinical through commercial phases.

Backem maintains four GMP-certified manufacturing sites located in Switzerland (Bubendorf, Vionnaz, and Sisslerfeld) and the United States (Torrance and Vista), plus an additional facility in St. Helens, UK. The company employs approximately 2,500 team members globally and reports managing over 150 ongoing CMC projects. Manufacturing capabilities span volumes from milligrams to multi-tonne commercial scales, supported by integrated analytical, quality, regulatory, and project management services. The company emphasizes vertical integration from synthesis of building blocks through final API production.

Capabilities

Supplements
Capsules
Ingredients
Vitamins

Tags

Also in Switzerland

Supplements — Capsules

See all in Switzerland →

Similar manufacturers

Also working in Supplements — Capsules